What does Financière de Tubize S.A. do?

Financière de Tubize S.A. (TUB.BR) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is TUB.BR's market cap?

Financière de Tubize S.A. (TUB.BR) has a market capitalization of approximately $9.35 billion, as of July 22, 2026, based on the most recent share price and shares outstanding.

Does TUB.BR pay a dividend?

Yes — Financière de Tubize S.A. (TUB.BR) pays a dividend monthly, with a trailing-twelve-month yield of 0.53%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

TUB.BR

Financière de Tubize S.A.

BRU·Biotechnology · Healthcare

€210.00€1.00+0.48%

Market cap€9.35B·Market closed·Jul 22 3:35 PM UTC

Price Chart

€210.00+€1.00 (+0.48%)today

+146.19%CAGR +19.75%

Select date range

FromTo

Jan 2, 1987Jul 22, 2021 → Jul 22, 2026· 5.0 yrsJul 22, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)0.23%

Annual Dividend (FWD)€0.49

Dividend Growth (5Y)−6.5%

Dividend Safety—

Payout Ratio53.4%

FCF Payout Ratio—

Most Recent Dividend€0.041

Ex-Dividend DateJun 12

Payment DateJun 26

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)+5.6%

EPS Growth (3Y)−27.3%

EPS Growth (5Y)−7.6%

Next Earnings DateMar 23

Last Report DateMar 23

Reported vs Estimate−€0.05

Earnings Surprise—

FinancialsFinancials Tab

Revenue€13.29K

Net Income€183.33M

Net Margin1,379,579.7%

Operating Cash Flow−€5.74M

Capital Expenditures€0.00

Free Cash Flow−€5.74M

Return on Equity9.7%

Return on Invested Capital−0.1%

Net Cash€1.27M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for TUB.BR and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how TUB.BR's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for TUB.BR and 80,000+ other tickers.

About Financière de Tubize S.A.

Financière de Tubize SA, headquartered in Brussels, Belgium, operates as a global biopharmaceutical firm, primarily through its investment in UCB. The company is dedicated to discovering and advancing innovative medicines and solutions focused on neurological and immunological disorders. Its current commercial offerings include Cimzia, an established treatment for a range of inflammatory conditions such as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis. For…

CEO: Eric Nys
Sector: Healthcare
Industry: Biotechnology
Exchange: BRU
Employees: 3
Website: www.financiere-tubize.be

Peers

Peers Tab

BIOS.BR

BioSenic S.A.

Cap

€1.3M

ALEMS.BR

European Medical Solutions

Cap

€17.6M

HYL.BR

Hyloris Pharmaceuticals S.A.

Cap

€129.1M

Latest News

News Tab

No recent news available.

Frequently Asked Questions About TUB.BR

What does Financière de Tubize S.A. do?: Financière de Tubize S.A. (TUB.BR) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is TUB.BR's market cap?: Financière de Tubize S.A. (TUB.BR) has a market capitalization of approximately $9.35 billion, as of July 22, 2026, based on the most recent share price and shares outstanding.
Does TUB.BR pay a dividend?: Yes — Financière de Tubize S.A. (TUB.BR) pays a dividend monthly, with a trailing-twelve-month yield of 0.53%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.